Physician profile
Callum Dupre
NPI 1942438999
$1,975.65
in general payments reported to CMS, 2019-2025
16 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $95.38 · 2021: $338 · 2022: $256 · 2023: $630 · 2024: $190 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863 · Consulting Fee: $150 · Education: $84.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.04 |
| Consulting Fee | $150.00 |
| Education | $84.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $450.00 | 2019-2023 | Tysabri |
| Inspire Medical Systems, INC. | $406.12 | 2021-2025 | Inspire |
| Harmony Biosciences LLC | $405.14 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $197.21 | 2019-2025 | Xywav |
| Axsome Therapeutics, INC. | $175.13 | 2023-2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $110.79 | 2022-2024 | Quviviq |
| Merck Sharp & Dohme LLC | $52.57 | 2023 | Belsomra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.85 | 2020 | |
| Eisai INC. | $28.80 | 2020 | |
| Pfizer INC. | $24.96 | 2025 | |
| Azurity Pharmaceuticals, INC. | $21.22 | 2023 | Horizant |
| Avadel Cns Pharmaceuticals, LLC | $17.52 | 2024 | Lumryz |
| Nevro Corp. | $17.03 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.62 | 2021 | |
| Vanda Pharmaceuticals INC. | $14.01 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3b Medical, INC. | $11.68 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callum Dupre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.